[1] Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi[J]. Circulation, 1987 ,75(5):1004-1011. [2] Albaeni A, Chatila K, Beydoun HA, et al. In-hospital left ventricular thrombus following ST-elevation myocardial infarction[J]. Int J Cardiol, 2020 , 15:299:1-6. [3] Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus[J]. Ther Adv Cardiovasc Dis,2017 ,11(8):203-213. [4] Shacham Y, Birati EY, Rogovski O, et al. Left ventricular thrombus formation and bleeding complications during continuous in-hospital anticoagulation for acute anterior myocardial infarction[J]. Isr Med Assoc J,2012, 14(12):742-6. [5] Mir JU, Raheel Jahangir J, Asfandyar Q, et al. Left ventricular thrombus in patients with acute anterior wall myocardial infarction[J]. J Ayub Med Coll Abbottabad ,2014 ,26(4):491. [6] Gianstefani S, Douiri A, Delithanasis I, et al. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention[J]. Am J Cardiol, 2014 ,113(7):1111. [7] Altnta B, Altnda R, Bilge, et al. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction[J]. Int J Cardiol,2019, 15(287):19-26. [8] Phan J, Nguyen T, French J, et al. Incidence and predictors of left ventricular thrombus formation following acute ST-segment elevation myocardial infarction: A serial cardiac MRI study[J]. Int J Cardiol Heart Vasc, 2019 ,4(24):100395. [9] Khoury S, Carmon S, Margolis G, et al. Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention[J]. Clin Res Cardiol, 2017 ,106(9):695-701. [10] Jiang YX, Jing LD, Jia YH. Clinical Characteristics and Risk Factors of Left Ventricular Thrombus after Acute Myocardial Infarction: A Matched Case-control Study[J]. Chin Med J (Engl), 2015 ,128(18):2415. [11] Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction[J]. Heart, 2012 ,98(23):1743. [12] Bakalli A, Georgievska-Ismail L, Ko inaj D, et al. Prevalence of left chamber cardiac thrombi in patients with dilated left ventricle at sinus rhythm: the role of transesophageal echocardiography[J]. J Clin Ultrasound, 2013 ,41(1):38-45. [13] Shacham Y, Leshem-Rubinow E, Ben Assa E, et al. Comparison of C-reactive protein and fibrinogen levels in patients having anterior wall ST-Segment elevation myocardial infarction with versus without left ventricular thrombus (from a primary percutaneous coronary intervention cohort)[J]. Am J Cardiol, 2013 ,112(1):57-60. [14] Acar Z, Ziyrek M, Korkmaz L, et al. Mean platelet volume at admission is a determinant of left ventricular thrombus formation after primary percutaneous coronary intervention for first anterior wall myocardial infarction[J]. Acta Cardiol, 2014 ,69(6):603. [15] O'Gara PT, Kushner FG, Ascheim DD,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013 ,61(4):78-140. [16] Turgay Yildirim, Akit E, Aydin F, et al. Efficacy of direct oral anticoagulants on left ventricular thrombus[J]. Blood Coagul Fibrinolysis, 2019 ,30(3):96-103. [17] 王华,梁延春.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789. [18] Januzzi JL Jr, Prescott MF, Butler J, et al. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction[J]. JAMA, 2019,322(11):1-11. [19] Almufleh A, Marbach J, Chih S, et al.Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients[J]. Am J Cardiovasc Dis, 2017 ,7(6):108-113. |